Organization: Health Canada
Year: 2023
Month: March
Request Number: A-2022-001137
Request Summary: Adverse Drug Reaction (ADR) for NINLARO. Report number: E2B_05754329. ADRs for IXAZOMIB. Report numbers: E2B_05765887, E2B_05775462, E2B_05769970, E2B_05769961, E2B_05769964. ADRs for ONDANSETRON. Report numbers: 001014425, 001010744, E2B_05712287, E2B_05775458.
Disposition: Disclosed in part
Number of pages: 224